(19)
(11) EP 4 798 713 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24802365.7

(22) Date of filing: 22.10.2024
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
A61P 25/28(2006.01)
C07K 14/47(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/1138; C12N 2310/14; C07K 14/47; C12N 2310/20; A61P 25/28
(86) International application number:
PCT/US2024/052306
(87) International publication number:
WO 2025/090427 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363592271 P

(71) Applicant: University of Rochester
Rochester, NY 14642 (US)

(72) Inventors:
  • GOLDMAN, Steven
    New York 14580 (US)
  • NEDERGAARD, Maiken
    Rochester, New York 14642 (US)
  • LONG, Carter
    Rochester, New York 14642 (US)

(74) Representative: Brand Murray Fuller LLP 
111 Wardour Street
London W1F 0UH
London W1F 0UH (GB)

   


(54) GLIAL-TARGETED RELIEF OF HYPEREXCITABILITY IN NEURODEGENERATIVE DISEASES